Navigation Links
BiOptix announces expansion of Board of Directors
Date:6/27/2012

BOULDER, Colo., June 27, 2012 /PRNewswire/ -- BiOptix announces the appointment of Michael W. Routh, Ph. D. to the Board of Directors of the firm, adding to a preeminent group of leaders driving BiOptix and its proprietary Enhanced Surface Plasmon Resonance platform toward continued success in the life science marketplace.

BiOptix, a leader in the Surface Plasmon Resonance space today announced the appointment of Michael W. Routh, Ph.D. to the Board of Directors.  "The appointment of Dr. Routh brings a wealth of analytical instrument sector knowledge to BiOptix," noted Rick Whitcomb, President and CEO of BiOptix.  "I'm excited to join the Board of Directors of BiOptix—BiOptix has a winning technology value proposition and will continue to exceed customer requirements with its proprietary Enhanced Surface Plasmon Resonance platform.  BiOptix has a world-class team driving the scientific discovery and commercialization process and I'm glad to be a part of this success story," noted Dr. Routh.   

Dr. Routh's career spans over 30 years in the analytical instrument industry split equally between top executive and senior functional leadership roles in such notable companies as Varian, Applied Research Laboratories, Baird, Thermo Fisher Scientific, BioRad and most recently, General Electric.  Dr. Routh earned both B.S. and M.S. degrees at Fresno State University and a Ph.D. degree from the University of Arizona, all in Analytical Chemistry.  

Dr. Routh joins the following individuals on the Board of Directors of BiOptix:

  • William Freytag, Ph.D – Chairman of the Board
  • Kyle Lefkoff – Director
  • Ron Lowy – Director
  • William Marshall, Ph.D – Director
  • Konstantin V. Severinov, Ph.D – Director
  • Sergey Polikarpov – Director
  • Richard Whitcomb – Director, President & CEO, BiOptix

In addition, Dr. Routh will be working with the Management Team of BiOptix:

  • Marty Stanton, Ph.D., Chief Scientific Officer
  • Ken Wilczek, Vice President, Sales & Marketing
  • Nolan Smith, Vice President, Finance
  • Slava Petropavlovskikh, Director, Research & Development, Co-Founder BiOptix

About BiOptix

BiOptix Diagnostics Corporation, a privately held firm based in Boulder, Colorado has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance.  BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com


'/>"/>
SOURCE BiOptix Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Modern Mobility Aids, Inc. Announces a Revised Agreement for the Acquisition of Lumigene
2. ChromaDex® Announces Financial Results for the Year Ended 2011
3. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
4. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
5. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
6. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
7. Medbox, Inc. Announces Top-Tier Rating by Dun & Bradstreet Credibility Corporation
8. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
9. Mass. Eye and Ear announces Curing Kids Fund grant recipients
10. Bay Area PV Consortium announces $7.5 million in grants to lower the cost of large-scale solar
11. BioMed Central announces winners of 6th Annual Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... Iowa (PRWEB) , ... October 12, 2017 , ... ... based in Vilnius, Lithuania, announced today that they have entered into a multiyear ... is to provide CRISPR researchers with additional tools for gene editing across all ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and ... Labs ), Inc. has been selected for membership in ARCS Alumni Hall ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
Breaking Biology Technology: